Literature DB >> 24310605

Investigation of the functional expression of purine and pyrimidine receptors in porcine isolated pancreatic arteries.

M Alsaqati1, S L F Chan, V Ralevic.   

Abstract

Receptors for purines and pyrimidines are expressed throughout the cardiovascular system. This study investigated their functional expression in porcine isolated pancreatic arteries. Pancreatic arteries (endothelium intact or denuded) were prepared for isometric tension recording and preconstricted with U46619, a thromboxane A(2) mimetic; adenosine-5'-diphosphate (ADP), uridine-5'-triphosphate (UTP) and MRS2768, a selective P2Y(2) agonist, were applied cumulatively, while adenosine-5'-triphosphate (ATP) and αβ-methylene-ATP (αβ-meATP) response curves were generated from single concentrations per tissue segment. Antagonists/enzyme inhibitors were applied prior to U46619 addition. ATP, αβ-meATP, UTP and MRS2768 induced vasoconstriction, with a potency order of αβ-meATP > MRS2768 > ATPUTP. Contractions to ATP and αβ-meATP were blocked by NF449, a selective P2X(1) receptor antagonist. The contraction induced by ATP, but not UTP, was followed by vasorelaxation. Endothelium removal and DUP 697, a cyclooxygenase-2 inhibitor, had no significant effect on contraction to ATP but attenuated that to UTP, indicating actions at distinct receptors. MRS2578, a selective P2Y(6) receptor antagonist, had no effect on contractions to UTP. ADP induced endothelium-dependent vasorelaxation which was inhibited by MRS2179, a selective P2Y(1) receptor antagonist, or SCH58261, a selective adenosine A(2A) receptor antagonist. The contractions to ATP and αβ-meATP were attributed to actions at P2X(1) receptors on the vascular smooth muscle, whereas it was shown for the first time that UTP induced an endothelium-dependent vasoconstriction which may involve P2Y(2) and/or P2Y(4) receptors. The relaxation induced by ADP is mediated by P2Y(1) and A(2A) adenosine receptors. Porcine pancreatic arteries appear to lack vasorelaxant P2Y(2) and P2Y(4) receptors.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24310605      PMCID: PMC4040170          DOI: 10.1007/s11302-013-9403-2

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  41 in total

Review 1.  Pathophysiology and therapeutic potential of purinergic signaling.

Authors:  Geoffrey Burnstock
Journal:  Pharmacol Rev       Date:  2006-03       Impact factor: 25.468

2.  Purinergic receptors in the endocrine and exocrine pancreas.

Authors:  I Novak
Journal:  Purinergic Signal       Date:  2007-12-11       Impact factor: 3.765

3.  Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenylyl cyclase.

Authors:  D Communi; C Govaerts; M Parmentier; J M Boeynaems
Journal:  J Biol Chem       Date:  1997-12-19       Impact factor: 5.157

4.  Activation of adenosine A1-receptor pathway induces edema formation in the pancreas of rats.

Authors:  A Satoh; T Shimosegawa; K Satoh; H Ito; Y Kohno; A Masamune; M Fujita; T Toyota
Journal:  Gastroenterology       Date:  2000-09       Impact factor: 22.682

5.  Intravascular ATP and coronary vasodilation in the isolated working rat heart.

Authors:  O Korchazhkina; G Wright; C Exley
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

6.  The involvement of smooth muscle P2X receptors in the prolonged vasorelaxation response to purine nucleotides in the rat mesenteric arterial bed.

Authors:  V Ralevic
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

7.  Relaxant effect of 2-methyl-thio-adenosine diphosphate on rat thoracic aorta: effect of clopidogrel.

Authors:  F Dol-Gleizes; A M Marés; P Savi; J M Herbert
Journal:  Eur J Pharmacol       Date:  1999-02-19       Impact factor: 4.432

8.  Dual regulation of pancreatic vascular tone by P2X and P2Y purinoceptor subtypes.

Authors:  D Hillaire-Buys; J Chapal; P Petit; M M Loubatières-Mariani
Journal:  Eur J Pharmacol       Date:  1991-07-09       Impact factor: 4.432

9.  Evidence for a vasoconstriction-mediating receptor for UTP, distinct from the P2 purinoceptor, in rabbit ear artery.

Authors:  I von Kügelgen; D Häussinger; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-11       Impact factor: 3.000

10.  Relative contribution of P2U- and P2Y-purinoceptors to endothelium-dependent vasodilatation in the golden hamster isolated mesenteric arterial bed.

Authors:  V Ralevic; G Burnstock
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

View more
  4 in total

1.  UDP-induced relaxation is enhanced in aorta from female obese Otsuka Long-Evans Tokushima Fatty rats.

Authors:  Shota Kobayashi; Takayuki Matsumoto; Makoto Ando; Maika Iguchi; Shun Watanabe; Kumiko Taguchi; Tsuneo Kobayashi
Journal:  Purinergic Signal       Date:  2017-11-29       Impact factor: 3.765

2.  Characterisation of P2Y receptor subtypes mediating vasodilation and vasoconstriction of rat pulmonary artery using selective antagonists.

Authors:  Markie O Dales; Callum Mitchell; Alison M Gurney; Robert M Drummond; Charles Kennedy
Journal:  Purinergic Signal       Date:  2022-08-26       Impact factor: 3.950

3.  Impaired UTP-induced relaxation in the carotid arteries of spontaneously hypertensive rats.

Authors:  Takayuki Matsumoto; Mihoka Kojima; Keisuke Takayanagi; Tomoki Katome; Kumiko Taguchi; Tsuneo Kobayashi
Journal:  Purinergic Signal       Date:  2020-08-29       Impact factor: 3.765

Review 4.  Role of the Purinergic P2Y2 Receptor in Pulmonary Hypertension.

Authors:  Mazen Shihan; Tatyana Novoyatleva; Thilo Lehmeyer; Akylbek Sydykov; Ralph T Schermuly
Journal:  Int J Environ Res Public Health       Date:  2021-10-20       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.